Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease

• Frederik Denorme ,

  Contributed equally to this work with: Frederik Denorme, Peter Kraft

  Affiliation Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  ⨯
• Peter Kraft ,

  Contributed equally to this work with: Frederik Denorme, Peter Kraft

  Affiliation Department of Neurology, University Hospital of Würzburg, Würzburg, Germany

  ⨯
• Inge Pareyn,

  Affiliation Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  ⨯
• Christiane Drechsler,

  Affiliation Department of Internal Medicine, University Hospital of Würzburg, Würzburg, Germany

  ⨯
• Hans Deckmyn,

  Affiliation Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  ⨯
• Karen Vanhoorelbeke,

  Affiliation Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  ⨯
• Christoph Kleinschnitz,

  Affiliation Department of Neurology, University Hospital Essen, Essen, Germany

  ⨯
• Simon F. De Meyer

  * E-mail: Simon.Demeyer@kuleuven.be

  Affiliation Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium

  http://orcid.org/0000-0002-1807-5882

  ⨯